Expansion Therapeutics News:
READ THE RELEASE
Successful A Round Funding & Next Steps
Site Under Construction
Transformative Oral Medicines for Severe RNA-Mediated Diseases
Small molecules, big difference
Expansion Therapeutics has significantly expanded on scientific founder Matt Disney’s breakthrough work in addressing Small Molecules interacting with RNA (SMiRNA).
The World of SMiRNA™
Targeting RNA, Curing Disease
for Major Neurological Diseases